1-14 of 14
tumor cells
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inflammation-driven activation of JAK/STAT signaling reversibly accelerates acute myeloid leukemia in vitro

Jan Habbel, Lucas Arnold, Yiyang Chen, Michael Möllmann, Kirsten Bruderek, Sven Brandau, Ulrich Dührsen, Maher Hanoun
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3000–3010.
https://doi.org/10.1182/bloodadvances.2019001292
Published: 2020
Includes: Supplemental data
Journal Articles

Inducible MyD88/CD40 synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells

Xiaomei Wang, Daniel L. Jasinski, Jan L. Medina, David M. Spencer, Aaron E. Foster, J. Henri Bayle
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1950–1964.
https://doi.org/10.1182/bloodadvances.2020001510
Published: 2020
Includes: Supplemental data
Journal Articles

Clonotypic heterogeneity in cutaneous T-cell lymphoma (mycosis fungoides) revealed by comprehensive whole-exome sequencing

Aishwarya Iyer, Dylan Hennessey, Sandra O’Keefe, Jordan Patterson, Weiwei Wang, Thomas Salopek, Gane Ka-Shu Wong, Robert Gniadecki
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1175–1184.
https://doi.org/10.1182/bloodadvances.2018027482
Published: 2019
Includes: Supplemental data
Journal Articles

Intratumoral platelet aggregate formation in a murine preclinical glioma model depends on podoplanin expression on tumor cells

Barbara Costa, Tanja Eisemann, Jens Strelau, Ingrid Spaan, Andrey Korshunov, Hai-Kun Liu, Peter Bugert, Peter Angel, Heike Peterziel
Journal: Blood Advances
Blood Adv (2019) 3 (7): 1092–1102.
https://doi.org/10.1182/bloodadvances.2018015966
Published: 2019
Includes: Supplemental data
Journal Articles

Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL

Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F. Kaminski, Sarah Cooley, Daniel J. Weisdorf, Daniel A. Vallera, Jeffrey S. Miller, Veronika Bachanova
Journal: Blood Advances
Blood Adv (2019) 3 (6): 897–907.
https://doi.org/10.1182/bloodadvances.2018029371
Published: 2019
Includes: Supplemental data
Journal Articles

Progression of mycosis fungoides occurs through divergence of tumor immunophenotype by differential expression of HLA-DR

Clinical Trials & Observations
Duncan Murray, Jack Luke McMurray, Suzy Eldershaw, Hayden Pearce, Nathaniel Davies, Julia J. Scarisbrick, Paul Moss
Journal: Blood Advances
Blood Adv (2019) 3 (4): 519–530.
https://doi.org/10.1182/bloodadvances.2018025114
Published: 2019
Includes: Supplemental data
Journal Articles

Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis

Kelly E. Johnson, Julia R. Ceglowski, Harvey G. Roweth, Jodi A. Forward, Mason D. Tippy, Saleh El-Husayni, Rajesh Kulenthirarajan, Michael W. Malloy, Kellie R. Machlus, Wendy Y. Chen, Joseph E. Italiano, Jr, Elisabeth M. Battinelli
Journal: Blood Advances
Blood Adv (2019) 3 (2): 198–211.
https://doi.org/10.1182/bloodadvances.2018026161
Published: 2019
Includes: Supplemental data
Journal Articles

Enhancing immunotherapy of STING agonist for lymphoma in preclinical models

Adrienne Sallets, Sophie Robinson, Adel Kardosh, Ronald Levy
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2230–2241.
https://doi.org/10.1182/bloodadvances.2018020040
Published: 2018
Includes: Supplemental data
Journal Articles

Cobalt hematoporphyrin inhibits CLEC-2–podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice

Nagaharu Tsukiji, Makoto Osada, Tomoyuki Sasaki, Toshiaki Shirai, Kaneo Satoh, Osamu Inoue, Norihiko Umetani, Chihiro Mochizuki, Tamio Saito, Soichi Kojima, Hideyuki Shinmori, Yukio Ozaki, Katsue Suzuki-Inoue
Journal: Blood Advances
Blood Adv (2018) 2 (17): 2214–2225.
https://doi.org/10.1182/bloodadvances.2018016261
Published: 2018
Includes: Supplemental data
Journal Articles

CLT030, a leukemic stem cell–targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia

Ying-Ping Jiang, Bob Y. Liu, Quan Zheng, Swapna Panuganti, Ruoying Chen, Jianyu Zhu, Madhavi Mishra, Jianqing Huang, Trang Dao-Pick, Sharmili Roy, XiaoXian Zhao, Jeffrey Lin, Gautam Banik, Eric D. Hsi, Ramkumar Mandalam, Jagath R. Junutula
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1738–1749.
https://doi.org/10.1182/bloodadvances.2018020107
Published: 2018
Includes: Supplemental data
Journal Articles

Analysis of the thrombotic and fibrinolytic activities of tumor cell–derived extracellular vesicles

Ludovic Durrieu, Alamelu Bharadwaj, David M. Waisman
Journal: Blood Advances
Blood Adv (2018) 2 (10): 1054–1065.
https://doi.org/10.1182/bloodadvances.2017015479
Published: 2018
Includes: Supplemental data
Journal Articles

Maintenance of telomere length in AML

Peter M. Lansdorp
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2467–2472.
https://doi.org/10.1182/bloodadvances.2017012112
Published: 2017
Journal Articles

Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment

W. Richard Burack, Janice M. Spence, John P. Spence, Stephen A. Spence, Philip J. Rock, Gautam N. Shenoy, Leonard D. Shultz, Richard B. Bankert, Steven H. Bernstein
Journal: Blood Advances
Blood Adv (2017) 1 (16): 1263–1273.
https://doi.org/10.1182/bloodadvances.2017005892
Published: 2017
Includes: Supplemental data
Journal Articles

High-throughput sequencing of the B-cell receptor in African Burkitt lymphoma reveals clues to pathogenesis

Global Advances
Katharine A. Lombardo, David G. Coffey, Alicia J. Morales, Christopher S. Carlson, Andrea M. H. Towlerton, Sarah E. Gerdts, Francis K. Nkrumah, Janet Neequaye, Robert J. Biggar, Jackson Orem, Corey Casper, Sam M. Mbulaiteye, Kishor G. Bhatia, Edus H. Warren
Journal: Blood Advances
Blood Adv (2017) 1 (9): 535–544.
https://doi.org/10.1182/bloodadvances.2016000794
Published: 2017
Includes: Supplemental data